About
Keivan Sadrerafi is a medicinal chemist and biotech operator currently serving as Vice President of Pharmaceutical Development & CMC at Cyclarity Therapeutics. Cyclarity states that he leads CMC activities across GMP drug-substance manufacturing, formulation, analytical strategy, and global regulatory submissions. He has also appeared as an author and inventor on publications and patents tied to Cyclarity and earlier BioVinc-associated research.
Areas of interest
biotechdrug developmentmedicinal chemistrypharmaceutical CMCcyclodextrin therapeuticsatherosclerosiscardiovascular diseaseanalytical chemistry